Conference · Washington, District of Columbia
Optimizing Bioassays for Biologics
Health · Pharmaceuticals · Biology
Key numbers
- Editions on record
- 1first in 2013
About Optimizing Bioassays for Biologics
Bioassays are a critical component of biologics drug discovery and development. However, ever-changing technology, approaches, and regulatory requirements make it difficult to keep projects on track and on budget. Cambridge Healthtech Institute’s Inaugural Optimizing Bioassays for Biologics will bring together key individuals from bioanalytical R&D, cell and antibody engineering, immunology, pharmacology, and preclinical and clinical development. Special focus will be given to the development and validation of potency assays, developing bioassays for multi-domain proteins, and establishing a standard for using cell-based vs. non-cell-based assays. Regulatory updates, expectations for novel constructs, and reference standards will also be shared. This conference is part of Immunogenicity Summit 2013.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2013 | 12–13 Nov 2013 | Hyatt Regency Washington on Capitol Hill Washington, District of Columbia | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Optimizing Bioassays for Biologics?
The next dates haven't been confirmed. The last edition we have on record was 12–13 Nov 2013.
Where is it held?
The last edition we have was at Hyatt Regency Washington on Capitol Hill, Washington, District of Columbia.